Atlas Trials

Bioequivalence Study of Perampanel Tablets 12 mg

Clinical trial NCT06450223 · COMPLETED

Trial details

NCT number
NCT06450223
Sponsor
Humanis Saglık Anonim Sirketi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Epilepsy
Start date
2023-09-14
Primary completion
2023-09-20
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.